|
⚲
|
| Keyboard |
| Typewriter Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0002156390 |
| Sale | 2026-01-08 (56.3 M Offered, 56.3 M Sold) |
| Fund | |
| Phone | 6099239289 |
| Address | 238 Main Street, Office 2162 Cambridge, MA 02142 |
| Source | [EDGAR] |
| Amount Raised ($M) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-09-21 (D) |
| Exemption | 506(b) |
| Duration | One year or less |
| Revenue | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Mikael Dolston | Director | |
| Laura Tadvalkar | Director | |
| Kenneth Horne | Director | |
| Matthew Stanton | Executive Officer |
| Comparable Firms | State | AUM |
|---|---|---|
|
Longwood Management LLC
✚
|
MA | |
|
Highland Capital Partners LLC
✚
|
MA | |
|
TA Associates LP
✚
|
MA | |
|
Greenwood Investments Inc
✚
|
MA | |
|
Windham Capital Management LLC
✚
|
MA | |
|
Bain Capital Fund X LP
✚
|
MA | |
|
Castine Capital Management LLC
✚
|
MA | |
|
RVP Management LLC
✚
|
MA | |
|
Averin Capital LLC
✚
|
MA | |
|
Curie Bio Operations LLC
✚
|
MA |